Product copy cat company, with minimal innovative products getting launched. Horrible mgd care strategies (except with National Payors). Goals distributed based on market potential without adjustments for mgd market limitations. Most managers are incompetnet, can NOT help you, and play favorites...like high school never ended. Ugh!!!
Amgen has a management style to periodically purge the organization and let go several hundred people.
Beware of managers coming from Amgen to your organization.
Horrible leadership especially in Rebecca M., Unrealistic sales goals for rare disease, weak bonus payout, we are literally paying our speakers to prescribe Vyvgart, our HUB sucks, our field reimbursement team was recruited straight from Wal-Mart, RBDs are clueless, oh and our CEO is a freak weirdo.
Not certain about its identity. Collecting second or third grade managers from big pharma who settle on company dime in Tiburon for comfortable retirement.
CEO compensation in 2022 18.4 mln
Net profit zero
Business model rare diseases
Meaning nonprofit like with no profit showing, but the top raking a lot of money